Abstract
A medium-pressure (MP) ultraviolet (UV) system was used to investigate the UV photolysis and UV/H 2O 2 oxidation of pharmaceutically active compounds (PhACs) that belong to different therapeutic classes and were found to occur in the aquatic environment. The results obtained in laboratory-grade water (LGW) and surface water (SW) were compared with low-pressure (LP) results reported previously. Overall, MP lamps proved to be more efficient to maximize the bench-scale degradation of the selected group of compounds (ketoprofen, naproxen, carbamazepine, ciprofloxacin, clofibric acid, and iohexol) by both UV photolysis and UV/H 2O 2 oxidation. Fundamental direct and indirect photolysis parameters obtained in LGW are reported and used to model the MP-UV photolysis and MP-UV/H 2O 2 oxidation of the pharmaceuticals in SW, predicting the experimental results very well.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
